Similar articles for PMID: 30373742

Year	Number of Results
1999	1
2000	1
2002	1
2003	1
2004	1
2005	1
2006	2
2007	1
2008	3
2009	5
2010	4
2011	7
2012	2
2013	10
2014	3
2015	13
2016	12
2017	12
2018	12
2019	2
2020	1
2021	2
2022	1

1

Reactivation of hepatitis B virus associated with immunosuppression therapy.

Lee JGH, Carruthers M, Ko HH. Lee JGH, et al. CMAJ. 2018 Oct 29;190(43):E1284. doi: 10.1503/cmaj.180389. CMAJ. 2018. PMID: 30373742 Free PMC article. Review. No abstract available.

2

Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.

Choi J, Lim YS. Choi J, et al. J Infect Dis. 2017 Nov 16;216(suppl_8):S778-S784. doi: 10.1093/infdis/jix178. J Infect Dis. 2017. PMID: 29156044

3

Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.

Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal AŞ, Köksal İ, Örmeci N, Tabak F. Aygen B, et al. Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263. Turk J Gastroenterol. 2018. PMID: 29755010 Free PMC article.

4

[Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy].

Amouri A, Chtourou L, Mnif L, Tahri N. Amouri A, et al. Presse Med. 2008 Nov;37(11):1591-8. doi: 10.1016/j.lpm.2008.03.011. Epub 2008 Jun 13. Presse Med. 2008. PMID: 18555638 Review. French.

5

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT; American Gastroenterological Association Institute. Reddy KR, et al. Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31. Gastroenterology. 2015. PMID: 25447850 Review. No abstract available.

6

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Perrillo RP, Gish R, Falck-Ytter YT. Perrillo RP, et al. Gastroenterology. 2015 Jan;148(1):221-244.e3. doi: 10.1053/j.gastro.2014.10.038. Epub 2014 Oct 31. Gastroenterology. 2015. PMID: 25447852 Review. No abstract available.

7

Reactivation of hepatitis B virus associated with chemotherapy and immunosuppressive agent.

Wijaya I, Hasan I. Wijaya I, et al. Acta Med Indones. 2013 Jan;45(1):61-6. Acta Med Indones. 2013. PMID: 23585411 Free article. Review.

8

Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.

Marrone A, Capoluongo N, D'Amore C, Pisaturo M, Esposito M, Guastafierro S, Siniscalchi I, Macera M, Boemio A, Onorato L, Rinaldi L, Minichini C, Adinolfi LE, Sagnelli E, Mastrullo L, Coppola N. Marrone A, et al. J Viral Hepat. 2018 Feb;25(2):198-204. doi: 10.1111/jvh.12802. Epub 2017 Nov 29. J Viral Hepat. 2018. PMID: 29029365

9

Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.

Viganò M, Serra G, Casella G, Grossi G, Lampertico P. Viganò M, et al. Expert Opin Biol Ther. 2016 Jul;16(7):917-26. doi: 10.1080/14712598.2016.1177017. Epub 2016 May 3. Expert Opin Biol Ther. 2016. PMID: 27088278 Review.

10

Prevention of Hepatitis B reactivation in the setting of immunosuppression.

Pattullo V. Pattullo V. Clin Mol Hepatol. 2016 Jun;22(2):219-37. doi: 10.3350/cmh.2016.0024. Epub 2016 Jun 13. Clin Mol Hepatol. 2016. PMID: 27291888 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed